DARZQURO Combination Subcutaneous Injection Tender - 146639419

Procurement Summary

Country: Japan

Summary: DARZQURO Combination Subcutaneous Injection and other 1 item

Deadline: 15 Sep 2026

Posting Date: 06 Aug 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 146639419

Document Ref. No.:

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

33194100 - Devices and instruments for infusion
33964000 - Embalming injecting tubes
33692500 - Injectable solutions

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

DARZQURO Combination Subcutaneous Injection and other 1 item
Classification: 0004 Medical & Pharmaceutical Products

Summay of Notice: ⑴ Official in charge of disbursement of the procuring entity : Masanobu Shigeta, Director, National Hospital Organization Kure Medical Center

⑵ Classification of the products to be procured : 4

⑶ Nature and quantity of the products to be purchased : DARZQURO Combination Subcutaneous Injection and other 1 item

⑷ Delivery period : From October 1, 2026 to September 30, 2027

⑸ Delivery place : National Hospital Organization Kure Medical Center

⑹ Qualification for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :

① not come under Article 5 of the Regulation concerning Contract for National Hospital Organization (NHO). Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause ;

② not come under Article 6 of the Regulation concerning Contract for NHO ;

③ have Grade A, B or C in "Sales of products" for participating in tenders by Ministry of Health, Labour and Welfare (Single qualification for every ministry and agency) in Chugoku Region ;

④ prove to have obtained the firstclass-license for selling drugs in accordance with the Pharmaceutical Affairs Law ;

⑤ prove that they can deliver the drugs on the date and to the place specified by the Obligating Officer ;

⑥ meet the qualification requirements which the Obligating Officer may specify in accordance with Article 4 of the Regulation ;

⑺ Time-limit for tender : 5 : 00 P.M. September 15, 2026

⑻ Contact point for the notice : Ayane Kosaka, Accounting Division, National Hospital Organization Kure Medical Center, 3-1 Aoyama-cho Kure-shi, Hiroshima-ken 737-0023, Japan. TEL 0823-22-3111 ext. 6317

Documents

 Tender Notice